CIP
AERI

Chartwell Investment Partners’s Aerie Pharmaceuticals AERI Stock Holding History

Chartwell Investment Partners’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-22,000
Closed -$423K – 440
2019
Q3 		$423K Sell
22,000
-48,484
-69% -$1.11M 0.01% 392
2019
Q2 		$2.08M Buy
70,484
+28,171
+67% +$1.09M 0.07% 316
2019
Q1 		$2.01M Buy
42,313
+18,578
+78% +$818K 0.07% 327
2018
Q4 		$857K Buy
23,735
+734
+3% +$34.4K 0.03% 406
2018
Q3 		$1.42M Buy
23,001
+32
+0.1% +$2.06K 0.04% 426
2018
Q2 		$1.55M Sell
22,969
-868
-4% -$48.6K 0.05% 406
2018
Q1 		$1.29M Sell
23,837
-321
-1% -$18K 0.04% 352
2017
Q4 		$1.44M Sell
24,158
-1,433
-6% -$86.9K 0.05% 362
2017
Q3 		$1.24M Buy
25,591
+791
+3% +$43.2K 0.04% 372
2017
Q2 		$1.3M Buy
24,800
+10
+0% +$466 0.05% 332
2017
Q1 		$1.12M Sell
24,790
-14,375
-37% -$641K 0.04% 338
2016
Q4 		$1.48M Sell
39,165
-67,550
-63% -$2.55M 0.05% 345
2016
Q3 		$4.03M Buy
+106,715
New +$2.35M 0.07% 281
2015
Q2 		– Sell
-354,045
Closed -$11.1M – 336
2015
Q1 		$11.1M Buy
354,045
+169,140
+91% +$4.9M 0.22% 176
2014
Q4 		$5.4M Buy
+184,905
New +$4.69M 0.11% 261

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Chartwell Investment Partners's AERI Position: Q4 2019 in Review

Chartwell Investment Partners sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 22,000 shares — an estimated $423K sold.

Chartwell Investment Partners first reported a position in AERI in Q4 2014 and held it in 15 quarters. The position peaked at $11.1M in Q1 2015. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

  • Chartwell Investment Partners reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Chartwell Investment Partners sold 22,000 Aerie Pharmaceuticals shares in Q4 2019, an estimated $423K.
  • Chartwell Investment Partners first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 15 quarters.
  • Chartwell Investment Partners's Aerie Pharmaceuticals position peaked at $11.1M in Q1 2015.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Chartwell Investment Partners's 13F filing for Q4 2019, filed 29 Jan 2020.